Jubilant Pharmova Statistics

Total Valuation

NSE:JUBLPHARMA has a market cap or net worth of INR 140.99 billion. The enterprise value is 163.39 billion.

Market Cap	140.99B
Enterprise Value	163.39B

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	158.40M
Shares Outstanding	n/a
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	63.36M

Valuation Ratios

The trailing PE ratio is 32.58 and the forward PE ratio is 26.14.

PE Ratio	32.58
Forward PE	26.14
PS Ratio	1.78
PB Ratio	2.15
P/TBV Ratio	5.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	37.76
EV / Sales	2.06
EV / EBITDA	14.43
EV / EBIT	19.34
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.44
Debt / EBITDA	2.55
Debt / FCF	n/a
Interest Coverage	4.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.38%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.82%
Revenue Per Employee	14.28M
Profits Per Employee	780,061
Employee Count	5,547
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:JUBLPHARMA has paid 2.15 billion in taxes.

Income Tax	2.15B
Effective Tax Rate	33.32%

Stock Price Statistics

The stock price has decreased by -10.59% in the last 52 weeks. The beta is 0.56, so NSE:JUBLPHARMA's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-10.59%
50-Day Moving Average	1,011.57
200-Day Moving Average	1,082.06
Relative Strength Index (RSI)	32.58
Average Volume (20 Days)	139,560

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:JUBLPHARMA had revenue of INR 79.18 billion and earned 4.33 billion in profits. Earnings per share was 27.24.

Revenue	79.18B
Gross Profit	51.43B
Operating Income	8.45B
Pretax Income	6.44B
Net Income	4.33B
EBITDA	10.70B
EBIT	8.45B
Earnings Per Share (EPS)	27.24

Full Income Statement

Balance Sheet

The company has 6.23 billion in cash and 28.83 billion in debt, with a net cash position of -22.60 billion.

Cash & Cash Equivalents	6.23B
Total Debt	28.83B
Net Cash	-22.60B
Net Cash Per Share	n/a
Equity (Book Value)	65.72B
Book Value Per Share	415.87
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 64.94%, with operating and profit margins of 10.68% and 5.46%.

Gross Margin	64.94%
Operating Margin	10.68%
Pretax Margin	8.13%
Profit Margin	5.46%
EBITDA Margin	13.52%
EBIT Margin	10.68%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.55%.

Dividend Per Share	5.00
Dividend Yield	0.55%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	0.49%
Earnings Yield	3.07%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.

Last Split Date	Mar 17, 2006
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1